Tyrosine kinase inhibitors induce mitochondrial dysfunction during cardiomyocyte differentiation through alteration of GATA4-mediated networks
By
Qing Liu,
Haodi Wu,
Qing-Jun Luo,
Chao Jiang,
Zhana Duren,
Kevin Van Bortle,
Ming-tao Zhao,
Bingqing Zhao,
Jun Liu,
David P. Marciano,
Brittany Lee-McMullen,
Chenchen Zhu,
Anil M Narasimha,
Joshua J. Gruber,
Andrew M. Lipchik,
Hongchao Guo,
Nathaniel K Watson,
Ming-Shian Tsai,
Takaaki Furihata,
Lei Tian,
Eric Wei,
Yingxin Li,
Lars M Steinmetz,
Wing Hung Wong,
Mark A Kay,
Joseph C. Wu,
Michael P. Snyder
Posted 05 May 2020
bioRxiv DOI: 10.1101/2020.05.04.077024
Maternal drug exposure during pregnancy increases the risks of developmental cardiotoxicity, leading to congenital heart defects (CHDs). In this study, we used human stem cells as an in-vitro system to interrogate the mechanisms underlying drug-induced toxicity during cardiomyocyte differentiation, including anticancer tyrosine kinase inhibitor (TKI) drugs (imatinib, sunitinib, and vandetanib). H1-ESCs were treated with these drugs at sublethal levels during cardiomyocyte differentiation. We found that early exposure to TKIs during differentiation induced obvious toxic effects in differentiated cardiomyocytes, including disarranged sarcomere structure, interrupted Ca2+-handling, and impaired mitochondrial function. As sunitinib exposure showed the most significant developmental cardiotoxicity of all TKIs, we further examine its effect with in-vivo experiments. Maternal sunitinib exposure caused fetal death, bioaccumulation, and histopathologic changes in the neonatal mice. Integrative analysis of both transcriptomic and chromatin accessibility landscapes revealed that TKI-exposure altered GATA4-mediated regulatory network, which included key mitochondrial genes. Overexpression of GATA4 with CRISPR-activation restored morphologies, contraction, and mitochondria function in cardiomyocytes upon TKI exposure early during differentiation. Altogether, our study identified a novel crosstalk mechanism between GATA4 activity and mitochondrial function during cardiomyocyte differentiation, and revealed potential therapeutic approaches for reducing TKI-induced developmental cardiotoxicity for human health. ### Competing Interest Statement The authors have declared no competing interest.
Download data
- Downloaded 391 times
- Download rankings, all-time:
- Site-wide: 67,838
- In systems biology: 1,632
- Year to date:
- Site-wide: 47,503
- Since beginning of last month:
- Site-wide: 32,951
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!